Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Allopurinol 20 mg/mL in SyrSpend SF pH4

Author(s):  Allen Loyd V Jr

Issue:  Sep/Oct 2019 - Volume 23, Number 5
View All Articles in Issue

Page(s):  406

Allopurinol 20 mg/mL in SyrSpend SF pH4 Page 1

Download in electronic PDF format for $75

Abstract:  A formulation for preparing Allopurinol 20 mg/mL in SyrSpend SF pH4. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: Loyd V. Allen Jr., PhD, RPh, allopurinol, formulation, hyperuricemia, chronic gout, gouty arthritis, gouty nephropathy, recurrent calcium oxalate crystals, cancer chemotherapy

Related Categories: FORMULATIONS, MUSCULOSKELETAL DISORDERS, UROLOGY/URINARY TRACT

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Allopurinol 20 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Sep/Oct 2019
Pg. 406

Allopurinol Sodium 4-mg/mL Injection
Allen Loyd V Jr
Jul/Aug 2013
Pg. 328

Compounding in the Pharmacy Curriculum: Beyond the Basics
Hinkle Amanda R
, Newton Gail D
May/Jun 2004
Pg. 181-185

Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh
Allen Loyd V Jr
Nov/Dec 2003
Pg. 449-450

Basics of Compounding for Cough
Allen Loyd V Jr
Nov/Dec 2004
Pg. 462-465

Basics of Compounding for the Treatment of Warts
Allen Loyd V Jr
Mar/Apr 2004
Pg. 126-129

Stability of Allopurinol Suspension Compounded from Tablets
Alexander Kenneth S
, Davar Nipun, Parker Gordon A
Mar/Apr 1997
Pg. 128-131

The History, Symptoms, Causes, Risk Factors, Types, Diagnosis, Treatments, and Prevention of Gout, Part 2
Williams LaVonn A
Jan/Feb 2019
Pg. 14-21

Physicochemical Stability of Compounded Allopurinol Suspensions in PCCA Base, SuspendIt
Pramar Yashoda V
, Mandal Tarun K, Bostanian Levon A, Le Giang, Morris Tommy C, Graves Richard A
Sep/Oct 2020
Pg. 413-419

Ketoconazole 20-mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
May/Jun 2017
Pg. 233

Ketoprofen 20-mg/mL in SyrSPend SF pH4 Oral Suspension
Allen Loyd V Jr
Jan/Feb 2019
Pg. 53

Sulfasalazine 100 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Nov/Dec 2019
Pg. 490

Diclofenac Sodium 5 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Jan/Feb 2021
Pg. 46

Pregabaline 20 mg/mL in SyrSpend SR pH4 Oral Suspension
Allen Loyd V Jr
Nov/Dec 2019
Pg. 488

Allopurinol 20-mg/mL Oral Liquid
Allen Loyd V Jr
May/Jun 1997
Pg. 174

Sulfadiazine 100 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Nov/Dec 2021
Pg. 508

Lorazepam 1 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Mar/Apr 2022
Pg. 143

Stability of Allopurinol, Amitriptyline Hydrochloride, Carbamazepine, Domperidone, Isoniazid, Ketoconazole, Lisinopril, Naproxen, Paracetamol (Acetaminophen), and Sertraline Hydrochloride in SyrSpend SF PH4 Oral Suspensions
Polonini Hudson C
, Loures Sharlene, de Araujo Edson Peter, Brandão Marcos Antônio F, Ferreira Anderson O
Sep/Oct 2016
Pg. 426-434

Penicillamine-D 50 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
Jan/Feb 2018
Pg. 55

Atenolol 1 mg/mL or 5 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
May/Jun 2018
Pg. 233

Return to Top